Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CI | Common Stock, $.01 Par Value | Options Exercise | $4.85M | +62.1K | +55.61% | $78.04 | 174K | May 7, 2021 | Direct | F1 |
transaction | CI | Common Stock, $.01 Par Value | Sale | -$7.68M | -29.4K | -16.91% | $261.24 | 144K | May 7, 2021 | Direct | F1, F2 |
transaction | CI | Common Stock, $.01 Par Value | Sale | -$8.52M | -32.7K | -22.66% | $260.45 | 112K | May 7, 2021 | Direct | F1, F3 |
transaction | CI | Common Stock, $.01 Par Value | Options Exercise | $1.12M | +14.4K | +12.85% | $78.04 | 126K | May 10, 2021 | Direct | F1 |
holding | CI | Common Stock, $.01 Par Value | 1.65K | May 7, 2021 | By 401(k) | F4 | |||||
holding | CI | Common Stock, $.01 Par Value | 425K | May 7, 2021 | By GRAT |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CI | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -62.1K | -81.23% | $0.00 | 14.4K | May 7, 2021 | Common Stock, $.01 Par Value | 62.1K | $78.04 | Direct | F1, F5 |
transaction | CI | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -14.4K | -100% | $0.00* | 0 | May 10, 2021 | Common Stock, $.01 Par Value | 14.4K | $78.04 | Direct | F1, F5 |
Id | Content |
---|---|
F1 | These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2021. |
F2 | Represents the weighted average price of the shares sold. The prices actually received ranged from $261.005 to $261.93 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. |
F3 | Represents the weighted average price of the shares sold. The prices actually received ranged from $260.00 to $260.99 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. |
F4 | Represents shares acquired through ongoing participation in Cigna's 401(k) Plan. |
F5 | This option was granted on February 26, 2014. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date. |